Truist Financial Lowers Price Target on Integer Holdings, Maintains “Buy” Rating in Latest Report

🌧️Trending News

Truist Financial, a leading financial services company, recently released a research report on INTEGER HOLDINGS ($NYSE:ITGR), a prominent player in the medical device industry. Headquartered in Plano, Texas, INTEGER HOLDINGS is a global medical device company that specializes in developing and manufacturing products for the healthcare industry. Their products are used in a wide range of medical applications, including cardiovascular, neuromodulation, and orthopedic surgeries. With a strong track record of innovation and a diverse portfolio of products, INTEGER HOLDINGS has established itself as a leader in the medical device market. This signifies their confidence in the company’s performance and growth potential.

However, Truist Financial has also revised their price target for the stock from $150.00 to $147.00. This change in price target is likely due to various factors, including overall market conditions and the company’s financial performance. While the stock has shown strong growth and stability over the years, it may have been affected by recent market fluctuations. As a result, Truist Financial has adjusted their short-term price target for the stock. Despite the revised price target, Truist Financial still maintains a positive view on INTEGER HOLDINGS and believes that it presents a promising investment opportunity. With a “buy” rating, they suggest that investors should consider adding INTEGER HOLDINGS to their portfolio. In conclusion, Truist Financial’s latest report on INTEGER HOLDINGS highlights the company’s strong position in the medical device industry and reaffirms its potential for growth. As always, investors should carefully consider all factors before making any investment decisions.

Share Price

On Friday, investors in Integer Holdings may have noticed a slight dip in the stock’s price as it opened at $128.63 and closed at $125.77. This decrease of 0.78% from the previous day’s closing price of $126.76 caught the attention of financial analysts at Truist Financial, leading them to lower their price target for the company’s stock. This reaffirms their belief in the company’s potential for growth and success in the market. It also serves as a positive indicator for investors, as a “Buy” rating typically suggests that a stock is expected to outperform the market. Truist Financial’s decision to lower the price target for Integer Holdings may be seen as a cautious move, taking into consideration the recent performance of the stock.

However, their overall positive outlook on the company’s future performance shows that they still have confidence in its long-term prospects. Overall, Truist Financial’s latest report on Integer Holdings serves as a reminder to investors to carefully consider the current market conditions and potential risks before making any investment decisions. However, their maintained “Buy” rating also highlights the promising future prospects of the company, making it one to watch for potential growth opportunities. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Integer Holdings. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Integer Holdings. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Integer Holdings. More…

Key Ratios Snapshot

Some of the financial key ratios for Integer Holdings are shown below. More…

Analysis

After conducting a thorough analysis of INTEGER HOLDINGS, I have determined that the company has a strong state of well-being. This is based on its high health score of 8/10 on the Star Chart, which takes into account its cashflows and debt. This suggests that INTEGER HOLDINGS has the financial capability to not only pay off its existing debt, but also fund future operations. According to our classification system, INTEGER HOLDINGS falls under the category of ‘cheetah’ companies. This means that it has achieved high levels of revenue or earnings growth, but may be considered less stable due to lower profitability. This could be a warning sign for some investors, as lower profitability could potentially impact the company’s ability to sustain its growth in the long run. However, there may be certain types of investors who are interested in a company like INTEGER HOLDINGS. For example, growth-oriented investors who are willing to take on some level of risk in exchange for potential high returns may see value in investing in a cheetah company like INTEGER HOLDINGS. Additionally, investors who are focused on cash flow and debt repayment may also find INTEGER HOLDINGS appealing based on its strong financials in those areas. It is also worth noting that INTEGER HOLDINGS has strengths and weaknesses in different areas. In terms of strengths, the company is strong in the areas of growth and profitability. This suggests that it has potential for continued success and may appeal to investors looking for companies with strong growth potential. On the other hand, INTEGER HOLDINGS is relatively weak in the areas of assets and dividends. This could be a concern for investors who prioritize stability and consistent returns. In conclusion, despite being classified as a cheetah company, INTEGER HOLDINGS has a solid state of well-being and may appeal to certain types of investors. However, it is important to carefully consider the company’s strengths and weaknesses before making any investment decisions. More…

Peers

The company designs, develops, manufactures, and markets medical devices and services worldwide. Integer’s competitors in the orthopedics industry include Polynovo Ltd, Globus Medical Inc, and Shenzhen Mindray Bio-Medical Electronics Co Ltd.

– Polynovo Ltd ($ASX:PNV)

Polynovo Ltd is a medical device company that designs, manufactures, and markets biodegradable scaffolds for use in tissue regeneration. The company has a market cap of 1.32B as of 2022 and a Return on Equity of -3.08%. Polynovo’s products are used in a variety of applications, including orthopedics, plastic surgery, and wound care. The company’s products are sold in over 30 countries worldwide.

– Globus Medical Inc ($NYSE:GMED)

Globus Medical Inc is a leading musculoskeletal solutions company. They design, develop, manufacture and market a comprehensive line of products for the orthopedic market. Their products are used in a wide variety of procedures, including spine, hip, and extremities. Globus Medical Inc has a market cap of 7.02B as of 2022, a Return on Equity of 7.24%. Globus Medical is committed to helping improve the quality of life for patients with musculoskeletal disorders. Their products are designed to provide solutions that enable patients to return to their active lifestyles.

– Shenzhen Mindray Bio-Medical Electronics Co Ltd ($SZSE:300760)

Shenzhen Mindray Bio-Medical Electronics Co Ltd is a medical device company that manufactures a range of medical devices and equipment. The company has a market capitalization of $366.53 billion as of 2022 and a return on equity of 23.24%. The company’s products are used in a variety of medical applications, including diagnostics, patient monitoring, and imaging.

Summary

Truist Financial has lowered their price target on Integer Holdings from $150.00 to $147.00, but maintained a “buy” rating on the stock. This suggests that they still believe the stock has potential for growth despite the lower price target. This may be due to their analysis of the company’s financial performance and future prospects.

Investors may consider this information when making decisions about whether to buy, sell, or hold shares in Integer Holdings. It also indicates that Truist Financial has confidence in the company’s long-term outlook and believes it is a good investment opportunity.